Prevention of Ebola virus disease through vaccination: where we are in 2018

Yves Levy (1) , Clifford Lane (2) , Peter Piot (3) , Abdul Habib Beavogui (4) , Mark Kieh (5) , Bailah Leigh (6) , Seydou S. Doumbia (7) , Eric D’ortenzio (1) , Claire Levy Marchal (1) , Jérôme Pierson (2) , Deborah Watson-Jones (3) , Vinh-Kim Nguyen (8) , Heidi J Larson (3) , Julia Lysander (5) , Christine Lacabaratz (1) , Rodolphe Thiébaut (9, 10) , Augustin Augier (11) , David Ishola (3) , Stephen Kennedy (5) , Geneviève Chene (10) , Brian Greenwood (3) , James D. Neaton (12) , Yazdan Yazdanpanah (1)

1 INSERM - Institut National de la Santé et de la Recherche Médicale
2 NIAID-NIH - National Institute of Allergy and Infectious Diseases [Bethesda]
3 LSHTM - London School of Hygiene and Tropical Medicine
4 CNFRSR - Centre National de Formation et de Recherche en Santé Rurale [Maférinyah, Guinée]
5 PREVAIL
6 USL - University of Sierra Leone
7 USTTB - Université des Sciences, des Techniques et des Technologies de Bamako
8 IHEID - Institut de hautes études internationales et du développement
9 SISTM - Statistics In System biology and Translational Medicine
10 BPH - Bordeaux population health
11 ALIMA - Alliance for International medical Action
12 University of Minnesota Medical School

Mots clés: SISTM; mORPH3Eus

Domaines: Santé publique et épidémiologie

Yves Levy, Clifford Lane, Peter Piot, Abdul Habib Beavogui, Mark Kieh, et al.. Prevention of Ebola virus disease through vaccination: where we are in 2018. The Lancet, 2018, 392 (10149), pp.787-790. ⟨10.1016/S0140-6736(18)31710-0⟩. ⟨hal-03160681⟩